Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone propionate for airway responsiveness in mild asthma
NCT00400855Phase 2Completed
- Sponsor
- GSK
- Start
- Jan 2005
- Primary completion
- Aug 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of fluticasone propionate in asthma, sponsored by GSK. Primary endpoint: Characterise the dose response curve following repeat inhaled doses of FP for 5 days in the AMP challenge model. Started Jan 2005; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00400855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00400855.